You can manage it by dividing the daily dose, using acidic body washes, staying hydrated, and consulting your doctor to safely adjust dosage
In addition, a 2024 study found that people taking another GLP-1 drug, liraglutide, had a 179% higher risk of developing NAION
Reference: Kin Wah Fung et al, GLP-1 RAs and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Older Patients With Diabetes, JAMA Ophthalmology (2025)
Williams is not part of this performance enhancement and fitness-optimization-through-peptides band of GLP-1 users
The article defines it as having tapered to the lowest dose or off entirely while maintaining weight stability, normal appetite signaling and stable blood sugar control over a sustained period afterward